DEKENOR

This brand name is authorized in Estonia, Croatia, Lithuania, Poland, Romania

Active ingredients

The drug DEKENOR contains one active pharmaceutical ingredient (API):

1	Dexketoprofen UNII 6KD9E78X68 - DEXKETOPROFEN
	Dexketoprofen belongs to the non-steroidal anti-inflammatory group of drugs. The mechanism of action of Dexketoprofen is related to the reduction of prostaglandin synthesis by the inhibition of cyclooxygenase pathway. Furthermore, the inhibition of the synthesis of prostaglandins could affect other inflammation mediators such as kinins, causing an indirect action which would be additional to the direct action.
	Read more about Dexketoprofen

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M01AE17	Dexketoprofen	M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AE Propionic acid derivatives
Discover more medicines within M01AE17

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1736535, 1736546, 1736557, 1792313, 1792324, 1792335, 1792346
HR	Agencija za lijekove i medicinske proizvode	HR-H-194707350
LT	Valstybinė vaistų kontrolės tarnyba	1085558, 1085559, 1085560
PL	Rejestru Produktów Leczniczych	100384055
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64522001, W64522002, W64522003, W67369001, W67369002, W67369003, W67369004